Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2)

被引:47
|
作者
Janke, Kirsten [1 ]
Brockmeier, Ulf [1 ]
Kuhlmann, Katja [2 ]
Eisenacher, Martin [2 ]
Nolde, Jan [3 ]
Meyer, Helmut E. [2 ]
Mairbaeurl, Heimo [4 ]
Metzen, Eric [1 ]
机构
[1] Univ Duisburg Essen, Fac Med, Inst Physiol, D-45147 Essen, Germany
[2] Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany
[3] Med Univ Lubeck, Dept Surg, D-23538 Lubeck, Germany
[4] Univ Heidelberg Hosp, Dept Internal Med Sports Med, D-69120 Heidelberg, Germany
关键词
Cell polarity; Hydroxylation; Hypoxia; Protein interaction; ANKYRIN REPEAT DOMAIN; BLOOD-BRAIN-BARRIER; ASPARAGINYL HYDROXYLASE; BETA-HYDROXYLATION; HYPOXIA; ALPHA; NOTCH; PERMEABILITY; HIF-1-ALPHA; STABILITY;
D O I
10.1242/jcs.117564
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The asparaginyl hydroxylase factor inhibiting HIF-1 (FIH-1) is an important suppressor of hypoxia-inducible factor (HIF) activity. In addition to HIF-alpha, FIH-1 was previously shown to hydroxylate other substrates within a highly conserved protein interaction domain, termed the ankyrin repeat domain (ARD). However, to date, the biological role of FIH-1-dependent ARD hydroxylation could not be clarified for any ARD-containing substrate. The apoptosis-stimulating p53-binding protein (ASPP) family members were initially identified as highly conserved regulators of the tumour suppressor p53. In addition, ASPP2 was shown to be important for the regulation of cell polarity through interaction with partitioning defective 3 homolog (Par-3). Using mass spectrometry we identified ASPP2 as a new substrate of FIH-1 but inhibitory ASPP (iASPP) was not hydroxylated. We demonstrated that ASPP2 asparagine 986 (N986) is a single hydroxylation site located within the ARD. ASPP2 protein levels and stability were not affected by depletion or inhibition of FIH-1. However, FIH-1 depletion did lead to impaired binding of Par-3 to ASPP2 while the interaction between ASPP2 and p53, apoptosis and proliferation of the cancer cells were not affected. Depletion of FIH-1 and incubation with the hydroxylase inhibitor dimethyloxalylglycine (DMOG) resulted in relocation of ASPP2 from cell-cell contacts to the cytosol. Our data thus demonstrate that protein interactions of ARD-containing substrates can be modified by FIH-1-dependent hydroxylation. The large cellular pool of ARD-containing proteins suggests that FIH-1 can affect a broad range of cellular functions and signalling pathways under certain conditions, for example, in response to severe hypoxia.
引用
收藏
页码:2629 / 2640
页数:12
相关论文
共 50 条
  • [31] Amphiregulin impairs apoptosis-stimulating protein 2 of p53 overexpression-induced apoptosis in hepatoma cells
    Liu, Kai
    Lin, Dongdong
    Ouyang, Yabo
    Pang, Lijun
    Guo, Xianghua
    Wang, Shanshan
    Zang, Yunjin
    Chen, Dexi
    TUMOR BIOLOGY, 2017, 39 (03)
  • [32] Expression of ASPP2k, a dominant-negative, oncogenic isoform of the Apoptosis-Stimulating Protein of p53-2 (ASPP2), accounts for a more aggressive tumorbiology in HER2+breast cancer
    Beck, I
    Ruiba, A.
    Sommer, I
    Aellig, V
    Ahrens, A. -L
    Kampa-Schittenhelm, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 98 - 98
  • [33] Attenuated Expression of Apoptosis Stimulating Protein of p53-2 (ASPP2) in Human Acute Leukemia Is Associated with Therapy Failure
    Schittenhelm, Marcus M.
    Illing, Barbara
    Ahmut, Figen
    Rasp, Katharina Henriette
    Blumenstock, Gunnar
    Doehner, Konstanze
    Lopez, Charles D.
    Kampa-Schittenhelm, Kerstin M.
    PLOS ONE, 2013, 8 (11):
  • [34] Hypermethylation of the Apoptosis Stimulating Protein of p53-2 (ASPP2) gene is associated with therapy failure in human acute leukemia
    Schittenhelm, M. M.
    Illing, B.
    Blumenstock, G.
    Akmut, F.
    Rasp, K-H
    Lopez, C. D.
    Kanz, L.
    Kampa-Schittenhelm, K. M.
    ONKOLOGIE, 2013, 36 : 49 - 50
  • [35] Apoptosis stimulating protein of p53 (ASPP2) haploinsufficiency promotes irradiation-induced high grade lymphomas in a mouse model.
    Kampa, Kerstin M.
    Akoba, Jared D.
    Chen, Dexi
    Beemer, Kelly
    Gay, Joel
    Zhu, Zhiyi
    Padiernos, Emerson
    Corless, Christopher
    Baily, Alexis
    Flemming, William H.
    Lopez, Charles D.
    BLOOD, 2007, 110 (11) : 776A - 777A
  • [36] Hepatitis C virus core protein interacts with p53-binding protein, 53BP2/Bbp/ASPP2, and inhibits p53-mediated apoptosis
    Cao, YH
    Hamada, T
    Matsui, T
    Date, T
    Iwabuchi, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 315 (04) : 788 - 795
  • [37] Inhibitory Member of the Apoptosis-stimulating Proteins of the p53 Family (iASPP) Interacts with Protein Phosphatase 1 via a Noncanonical Binding Motif
    Llanos, Susana
    Royer, Christophe
    Lu, Min
    Bergamaschi, Daniele
    Lee, Wen Hwa
    Lu, Xin
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (50) : 43039 - 43044
  • [38] The DEAD box protein Ddx42p modulates the function of ASPP2, a stimulator of apoptosis
    Uhlmann-Schiffler, H.
    Kiermayer, S.
    Stahl, H.
    ONCOGENE, 2009, 28 (20) : 2065 - 2073
  • [39] Inhibitory member of the apoptosis-stimulating protein of p53 (ASPP) family promotes growth and tumorigenesis in human p53-deficient prostate cancer cells
    B Zhang
    H J Xiao
    J Chen
    X Tao
    L H Cai
    Prostate Cancer and Prostatic Diseases, 2011, 14 : 219 - 224
  • [40] The DEAD box protein Ddx42p modulates the function of ASPP2, a stimulator of apoptosis
    H Uhlmann-Schiffler
    S Kiermayer
    H Stahl
    Oncogene, 2009, 28 : 2065 - 2073